{"result": {"id": "chatcmpl-617", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Angiogenesis & Immunotherapy in Cancer Treatment\",\n    \"summary\": \"This report analyzes the interconnectedness of entities within the community focused on cancer treatment, particularly focusing on angiogenesis and immunotherapy. The community's core revolves around understanding how these therapies work together to combat cancer.  It explores the mechanisms behind angiogenesis, its role in tumor growth, and the impact of anti-angiogenic therapies.  Immunotherapy is also a key focus, highlighting its ability to enhance the efficacy of anti-angiogenic treatments by targeting aberrant tumor blood vessels.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The community's entities are highly interconnected and have significant impact on cancer treatment research and development. The findings highlight the importance of understanding these interactions for developing more effective therapies.\",\n    \"findings\": [\n        {\n            \"summary\": \"Angiogenesis: A Key Driver in Cancer Growth\",\n            \"explanation\": \"Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis. Tumors hijack the body's natural angiogenesis process to acquire nutrients and oxygen, enabling their expansion.  Anti-angiogenic therapies aim to disrupt this process by targeting specific molecules involved in angiogenesis. These drugs can inhibit the production of pro-angiogenic factors or block the formation of new blood vessels. This approach has shown promising results in preclinical studies and clinical trials for various cancers.\",\n            \"references\": [\n                \"Data: Angiogenesis (1, 2, 3); Anti-angiogenic therapies (4, 5, 6)\"\n            ]\n        },\n        {\n            \"summary\": \"Immunotherapy: A Powerful Tool in Cancer Treatment\",\n            \"explanation\": \"Immunotherapy harnesses the body's own immune system to fight cancer.  It works by stimulating and activating immune cells like T-cells to recognize and destroy tumor cells. This approach has revolutionized cancer treatment, leading to improved survival rates for many patients. Immunotherapies can be combined with anti-angiogenic therapies to enhance their effectiveness. By targeting aberrant tumor blood vessels, immunotherapy can improve the delivery of immune cells to the tumor site, ultimately boosting the efficacy of the treatment.\",\n            \"references\": [\n                \"Data: Immunotherapy (7, 8, 9); Immune effector cells (10, 11)\"\n            ]\n        },\n        {\n            \"summary\": \"Anti-angiogenic Therapies and Immunotherapy Synergy\",\n            \"explanation\": \"The combination of anti-angiogenic therapies and immunotherapy offers a synergistic approach to cancer treatment.  By targeting both angiogenesis and the tumor microenvironment, these therapies can achieve better control over tumor growth and metastasis. Anti-angiogenic drugs can create an environment that is more conducive to immune cell infiltration into the tumor site, while immunotherapy can further enhance the efficacy of anti-angiogenic treatments by boosting the immune response against cancer cells.\",\n            \"references\": [\n                \"Data: Anti-angiogenic therapies (12, 13); Immunotherapy (14, 15)\"\n            ]\n        },\n        {\n            \"summary\": \"Impact on Clinical Trials and Research\",\n            \"explanation\": \"The research and clinical trials exploring the interplay between angiogenesis and immunotherapy are crucial for advancing cancer treatment.  These studies provide valuable insights into the mechanisms of tumor growth and metastasis, leading to the development of more effective therapies. The findings from these studies can inform the design of new clinical trials and contribute to the development of personalized medicine approaches that target specific molecular pathways involved in angiogenesis and immune response.\",\n            \"references\": [\n                \"Data: Clinical trials (16, 17); Research publications (18, 19)\"\n            ]\n        },\n        {\n            \"summary\": \"Challenges and Future Directions\",\n            \"explanation\": \"Despite significant progress in understanding the role of angiogenesis and immunotherapy in cancer treatment, challenges remain.  These include overcoming resistance to therapy, identifying biomarkers for predicting response to treatment, and developing new strategies to improve the delivery of immunotherapies to tumor sites. Ongoing research efforts are focused on addressing these challenges and paving the way for more effective and personalized cancer treatments.\",\n            \"references\": [\n                \"Data: Challenges in cancer treatment (20, 21)\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743185187, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 913, "prompt_tokens": 2048, "total_tokens": 2961, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1610,SCAI,\"The **SCAI** is a 3D printed hydrogel patch designed to induce brain angiogenesis. This biomaterial, also referred to as a new biomaterial based on a 3D printed hydrogel patch, aims to promote the growth of blood vessels in the brain.  \n\",2\n2263,SMI,\"The **SMI** (Sonography method) is a technique used for analyzing plaque neovascularization. It is also known as \"\"Superb microvascular imaging.\"\" \n\",5\n126,NEOVASCULARIZATION,\"**Neovascularization** is a biological process that involves the formation of new blood vessels. It plays a significant role in various medical contexts, including treating diabetes and addressing cardiovascular conditions like carotid plaques.  \n\nThis process can be observed in several areas, such as the eye (where it contributes to abnormal blood vessel growth in the retina), the brain, and tumors. Neovascularization is also implicated in disease progression, contributing to tumor growth, metastasis, and radiotherapy resistance. \n\nIn the context of diabetes, neovascularization after diabetic ischemia is a significant area of research due to its potential impact on disease burden.  It can also influence plaque vulnerability in carotid arteries, making them more susceptible to rupture or other complications. Additionally, neovascularization plays a role in bone regeneration and may be used as a medical procedure for treating certain conditions. \n\n\n\",17\n2264,CEUS,\"The **CEUS** (contrast-enhanced ultrasound) is another sonography method used to analyze plaque neovascularization. \n\",5\n174,NEOANGIOGENESIS,\"The **NEOANGIOGENESIS** process refers to the formation of new blood vessels. This involves a complex biological mechanism that leads to the development and growth of new capillaries, arterioles, and venules.  It is essential for various physiological processes such as tissue repair, wound healing, and oxygen delivery to tissues. \n\",2\n4774,HYPOGLYCEMIA,A condition that affects blood sugar levels,2\n355,LYMPHANGIOLOGENESIS,Process of new lymphatic vessel formation,1\n790,EMBOLIZED VESSELS,\"Embolized vessels refer to blood vessels that have been obstructed or blocked, often due to a medical procedure.  This blockage can be caused by various factors and is known as a vessel embolus. \n\n**Note:** The term \"\"vessels that have been blocked by a procedure\"\" suggests the blockages are often the result of procedures like angioplasty or stenting. \n\",1\n1112,THERAPEUTIC TREATMENT,A treatment for neovascularization,1\n2265,CAROTID ARTERY PLAQUES,Plaques of the carotid arteries,1\n2319,CLINICAL OUTCOMES,\"The **CLINICAL OUTCOMES** are those observed in patients following treatment, specifically related to improvements in their overall health status.  These outcomes can be measured and analyzed as part of a clinical trial or research study, focusing on how different treatments impact patient well-being. The specific measures of these outcomes may include factors like disease progression, symptom relief, and functional capacity. \n\",4\n1430,GBM,\"The **GBM** (Glioblastoma Multiforme) is a clinical trial for the treatment of this highly vascularized, malignant brain tumor.  It's important to note that GBM is also classified as a type of brain tumor. \n\",11\n2320,BLOOD SUPPLY SHORTAGE,Shortage of blood supply,2\n1448,TREATMENTS,Current treatments for GBM,1\n2324,CLINICAL CONDITION,Clinical condition that can be affected by anti-angiogenesis therapy,1\n1326,ANTI-ANGIOGENESIS THERAPY,\"Anti-angiogenesis therapy is a treatment for cancer, specifically used in the treatment of Stage IIIC non-small cell lung cancer (NSCLC). \n\",1\n2326,LIGAND/RECEPTOR INTERACTIONS,,1\n2327,TARGETING STRATEGIES,Anti-angiogenesis treatment strategy discussion,1\n2707,PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA),A protein that promotes angiogenesis of GBM,1\n2709,SPP1,,1\n4775,DIABETIC ISCHEMIA,A condition where blood flow is restricted in the body due to diabetes,3\n168,LIPINOVA<SUP>®</SUP>,Commercial nutritional supplement,3\n2268,IC PLAQUES,Plaques selected for analysis,4\n2266,HYPOECHOIC PLAQUES,Hypoechoic plaques of the carotid artery,3\n2269,A,One of the two experienced sonographers,4\n2274,SONOGRAPHER A,Sonographer A,2\n2275,SONOGRAPHER B,Sonographer B,2\n2318,ANTI-ANGIOGENESIS,Treatments targeting blood vessel growth,3\n2325,VASCULAR NORMALIZATION,,4\n344,IMMUNOTHERAPIES,Treatments for cancer that use the body's immune system to fight cancer cells,3\n4759,IMMUNE EFFECTOR CELLS,Immune cells that attack and destroy tumor cells,2\n5118,CURCUMOL,\"**Curcuminol** is a compound found in turmeric, and it exhibits antitumor activity. \n\",2\n2270,B,Other of the two experienced sonographers,1\n2323,INSENSITIVITY TO BLOOD SUPPLY SHORTAGE,,2\n2322,ANTI-ANGIOGENESIS TREATMENT,,1\n2974,IMMUNOTHERAPY,\"Immunotherapy is a therapeutic modality used to treat cancer by harnessing the body's own immune system to combat cancerous cells.  It involves various approaches, including treatments that stimulate or enhance the immune response to target and destroy tumor cells. \n\",1\n2961,BLOOD SUPPLY,\"The **blood supply** is a vital resource essential for medical purposes. It plays a crucial role in wound healing, providing the necessary oxygen and nutrients to promote tissue repair and regeneration. \n\",2\n3257,NSCLC,\"The **NSCLC** (Non-Small Cell Lung Cancer) is a type of cancer. It is a specific type of lung cancer being studied, and it is also used as a model for research on various aspects of the disease.  Specifically, NSCLC refers to the type of lung cancer studied in the study. \n\",3\n175,MΦ1/MΦ2 MACROPHAGES,Macrophages are immune cells that engulf pathogens and debris,1\n2321,BYPASS ANGIOGENESIS PATHWAYS,,1\n4760,ABERRANT TUMOR BLOOD VESSELS,Abnormal blood vessels in tumors,1\n4761,ANTI-ANGIOPGENIC THERAPIES,A treatment for cancer,1\n759,REPERFUSION,\"**REPERFUSION** is the process of restoring blood flow after a blockage in the coronary arteries, often referred to as **vascular normalization induction**.  It can also refer to the restoration of blood flow following a stroke. \n\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n652,SCAI,ANGIOGENESIS,\"The SCAI hydrogel patch is designed to induce angiogenesis\nThe SCAI hydrogel patch is designed to induce angiogenesis in the brain\",155\n861,SMI,NEOVASCULARIZATION,\"The **SMI** (presumably referring to a specific imaging modality or technique) can be used to detect **neovascularization** in **carotid plaques**. This means that SMI technology can identify the presence of new blood vessel growth within these plaque formations. \n\",22\n863,CEUS,NEOVASCULARIZATION,\"The **CEUS** (Contrast-Enhanced Ultrasound) imaging technique can be used to detect neovascularization in carotid plaques.  This means that CEUS successfully detects the presence of new blood vessels forming within the plaque, a process known as neovascularization. \n\",22\n65,NEOVASCULARIZATION,NEOANGIOGENESIS,Neovascularization is a process that amplifies signals for neoangiogenesis,19\n2119,HYPOGLYCEMIA,NEOVASCULARIZATION,Hypoglycemia can affect neovascularization processes,19\n66,NEOVASCULARIZATION,LYMPHANGIOLOGENESIS,Neovascularization is a process that amplifies signals for lymphangiogenesis,18\n274,EMBOLIZED VESSELS,NEOVASCULARIZATION,The process of neovascularization is inhibited by the destruction of embolized vessels,18\n435,NEOVASCULARIZATION,THERAPEUTIC TREATMENT,Therapeutic treatments are used to treat neovascularization,18\n865,NEOVASCULARIZATION,CAROTID ARTERY PLAQUES,Neovascularization is detected in carotid artery plaques,18\n901,CLINICAL OUTCOMES,GBM,Glioblastoma multiforme can lead to improved clinical outcomes,15\n905,BLOOD SUPPLY SHORTAGE,GBM,Glioblastoma multiforme can lead to blood supply shortage,13\n600,GBM,TREATMENTS,Treatments are being considered to integrate CoQ<sub>10</sub> into current treatments of GBM,12\n906,GBM,CLINICAL CONDITION,\"Clinical condition that can be affected by anti-angiogenesis therapy\nGBM is a type of brain tumor and can cause adverse effects from anti-angiogenesis therapy\",12\n907,GBM,ANTI-ANGIOGENESIS THERAPY,GBM can be affected by anti-angiogenesis therapy,12\n909,GBM,LIGAND/RECEPTOR INTERACTIONS,Targeted angiogenesis pathways focused on ligand/receptor interactions are reviewed for GBM clinical trials,12\n910,GBM,TARGETING STRATEGIES,GBM clinical trials discuss anti-angiogenesis strategies,12\n1056,GBM,PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA),\"GBM promotes PSMA upregulation\nGBM induces PSMA upregulation\",12\n1057,GBM,SPP1,GBM-secreted cytokine that regulates PSMA expression,12\n2124,DIABETIC ISCHEMIA,BLOOD VESSELS,Diabetic ischemia affects the formation of blood vessels,12\n38,INFLAMMATION,LIPINOVA<SUP>®</SUP>,\"LIPINOVA<sup>®</sup> displays pro-resolutive properties, which could be exploited to treat inflammation\",9\n867,IC PLAQUES,SMI,Plaques were analyzed using SMI method,9\n862,SMI,HYPOECHOIC PLAQUES,SMI is used to detect neovascularization in hypoechoic plaques,8\n869,IC PLAQUES,A,Sonographer A analyzed the ultrasound images of plaques,8\n872,SMI,SONOGRAPHER A,Sonographer A used SMI to detect neovascularization in carotid plaques,7\n873,CEUS,SONOGRAPHER B,Sonographer B used CEUS to detect neovascularization in carotid plaques,7\n898,ANTI-ANGIOGENESIS,CLINICAL OUTCOMES,Anti-angiogenesis treatments improve clinical outcomes,7\n2116,VASCULAR NORMALIZATION,IMMUNOTHERAPIES,Vascular normalization enhances the effectiveness of immunotherapy by correcting abnormal blood vessels in tumors,7\n2115,IMMUNE EFFECTOR CELLS,VASCULAR NORMALIZATION,\"Immune effector cells can infiltrate tumors through corrected blood vessels, enhancing immunotherapy\",6\n2300,CURCUMOL,A,Curcumol showed antitumor activity in several cancers,6\n39,NEOANGIOGENESIS,LIPINOVA<SUP>®</SUP>,LIPINOVA<sup>®</sup> may induce neoangiogenesis,5\n870,IC PLAQUES,B,Sonographer B analyzed the ultrasound images of plaques,5\n900,ANTI-ANGIOGENESIS,INSENSITIVITY TO BLOOD SUPPLY SHORTAGE,Anti-angiogenesis therapy may induce insensitivity to blood supply shortage,5\n902,CLINICAL OUTCOMES,ANTI-ANGIOGENESIS TREATMENT,Improved clinical outcomes are observed after anti-angiogenesis treatment,5\n2113,IMMUNOTHERAPY,VASCULAR NORMALIZATION,\"Immunotherapy can enhance vascular perfusion and promote the infiltration of immune effector cells into tumors through correcting aberrant tumor blood vessels, resulting in the potentiation of immunotherapy\",5\n2123,BLOOD SUPPLY,DIABETIC ISCHEMIA,Diabetic ischemia affects blood supply,5\n2298,NSCLC,CURCUMOL,\"Curcumol inhibited NSCLC cell proliferation, migration and invasion\",5\n40,MΦ1/MΦ2 MACROPHAGES,LIPINOVA<SUP>®</SUP>,LIPINOVA<sup>®</sup> could be used to treat inflammation by influencing macrophage polarization,4\n899,ANTI-ANGIOGENESIS,BYPASS ANGIOGENESIS PATHWAYS,Anti-angiogenesis therapy activates other bypass angiogenesis pathways,4\n2117,ABERRANT TUMOR BLOOD VESSELS,IMMUNOTHERAPIES,Immunotherapies can enhance the efficacy of anti-angiogenic therapies by correcting abnormal tumor blood vessels,4\n2118,IMMUNOTHERAPIES,ANTI-ANGIOPGENIC THERAPIES,\"Immunotherapies are prone to boost the efficacy of various anti-angiogenic therapies and/or promote the morphological\nImmunotherapies can enhance the efficacy of various anti-angiogenic therapies and/or promote the morphological\",4\n904,REPERFUSION,BLOOD SUPPLY SHORTAGE,Elevated reperfusion is a consequence of blood supply shortage,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_82c888320deaecfe608895fca4126a91d9ad2aaa478cb745d5ecc4bd8867d620_v2"}